RxDoctor Payments Data

Hillary Mitchell

Family · Longview, TXNPI 1992161301

Payments from drug & device makers

$10,099in general payments, 2019–2025

Across 147 payments — averaging $68.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Axsome Therapeutics, Inc.$8K
  • Alkermes, Inc.$406
  • AbbVie$292
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$148
  • Otsuka America Pharmaceutical, Inc.$139
  • Lundbeck LLC$135
  • plus $702 from 12 others

What the payments were for

  • Consulting fees$5,87558%
  • Speaking & faculty fees$2,00020%
  • Travel & lodging$1331%
  • Food & beverage$2,03820%
  • Education$531%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,099 in reported general payments places this provider in the 95th percentile of 15,456 family providers in Texas.

See all family providers in Texas

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ondansetron OdtOndansetron24$402
Lorazepam12$103

Paid to pharmacies, not to this prescriber.

Other family in Longview

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →